Novartis | NOVN - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 384.69B 19.14B 2026-03
Alcon AG USD 37.06B 5.98B 2026-03
Almirall EUR 2.76B 472.53M 2025-12
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Fresenius Medical Care EUR 11.32B 642.58M 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
J&J USD 579.15B 78.91B 2026-03
Lakefront Biotherapeutics EUR 1.73B 119.93M 2026-03
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 46.78B 6.52B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 307.76B 15.54B 2026-03
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Orion EUR 9.83B 890.75M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Philips EUR 22.47B 96.29M 2026-03
Recordati EUR 10.26B 104.56M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12